&nbsp;

fitp-map-ED-22-11-19.html

Nov 2019

Document

fit-nov-sec-try-22-11-19.xml

Nov 2019

Document

fitp-map-ED-3-try-22-11-19.html

Nov 2019

Regimen

FEC-D+PERT+TRAS

Cancer Type:

Breast

Intent: Curative, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

PERTuzumab (Unfunded),

trastuzumab

Quick Link(s):

Regimen Monograph

Apr 2023

Document

FINAL-CAR-T-cell_Therapy_for_Pediatric_and_Young_Adults_with_Relapsed_or_RefractoryB-cell_ALL_Version_1.0-2Dec2019

Dec 2019

Regimen

LENV

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Palliative

Drugs Used:

lenvatinib (Unfunded)

Quick Link(s):

Regimen Monograph

Sep 2020

Document

fit-28-1-20.xml

Jan 2020

Document

fit-28-1-20.html

Jan 2020

Regimen

LIPOCYTADAUN(CONS)

Cancer Type:

Hematologic

Intent: Curative, Palliative

Funding:

New Drug Funding Program

Liposomal Daunorubicin and Liposomal Cytarabine (Outpatient) - Previously Untreated Acute Myeloid Leukemia

liposomal DAUNOrubicin / liposomal cytarabine

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2023

Regimen

LENV

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

Exceptional Access Program

lenvatinib - For the treatment of unresectable advanced hepatocellular carcinoma according to clinical criteria

Drugs Used:

lenvatinib

Quick Link(s):

Regimen Monograph

Mar 2023

Document